Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)

Kristen Krysko; Jennifer Graves; Mary Rensel; Bianca Weinstock-Guttman; Alice Rutatangwa; Gregory Aaen; Anita Belman; Leslie Benson; Tanuja Chitnis; Mark Gorman; Manu Goyal; Yolanda Harris; Lauren Krupp; Timothy Lotze; Soe Mar; Manikum Moodley; Jayne Ness; Moses Rodriguez; John Rose; Teri Schreiner; Jan-Mendelt Tillema; Michael Waltz; T. Charles Casper; Emmanuelle Waubant

doi:10.1212/WNL.94.15_supplement.625

Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)

Kristen Krysko
, Jennifer Graves
, Mary Rensel
, Bianca Weinstock-Guttman
, Alice Rutatangwa
, Gregory Aaen
, Anita Belman
, Leslie Benson
, Tanuja Chitnis
, Mark Gorman
, Manu Goyal
, Yolanda Harris
, Lauren Krupp
, Timothy Lotze
, Soe Mar
, Manikum Moodley
, Jayne Ness
, Moses Rodriguez
, John Rose
, Teri Schreiner

Jan-Mendelt Tillema, Michael Waltz, T. Charles Casper, Emmanuelle Waubant

Pediatrics

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	American English
Journal	Neurology
Volume	94
Issue number	15 supplement
DOIs	https://doi.org/10.1212/WNL.94.15_supplement.625
State	Published - Apr 14 2020

Disciplines

Family Medicine
Medicine and Health Sciences

Access to Document

10.1212/WNL.94.15_supplement.625

OpenUrl availability

Full text

Cite this

Krysko, K., Graves, J., Rensel, M., Weinstock-Guttman, B., Rutatangwa, A., Aaen, G., Belman, A., Benson, L., Chitnis, T., Gorman, M., Goyal, M., Harris, Y., Krupp, L., Lotze, T., Mar, S., Moodley, M., Ness, J., Rodriguez, M., Rose, J., ... Waubant, E. (2020). Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625). Neurology, 94(15 supplement). https://doi.org/10.1212/WNL.94.15_supplement.625

Krysko, K, Graves, J, Rensel, M, Weinstock-Guttman, B, Rutatangwa, A, Aaen, G, Belman, A, Benson, L, Chitnis, T, Gorman, M, Goyal, M, Harris, Y, Krupp, L, Lotze, T, Mar, S, Moodley, M, Ness, J, Rodriguez, M, Rose, J, Schreiner, T, Tillema, J-M, Waltz, M, Casper, TC & Waubant, E 2020, 'Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)', Neurology, vol. 94, no. 15 supplement. https://doi.org/10.1212/WNL.94.15_supplement.625

@article{8342957f8d904d409cbc104e82f6712b,

title = "Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)",

author = "Kristen Krysko and Jennifer Graves and Mary Rensel and Bianca Weinstock-Guttman and Alice Rutatangwa and Gregory Aaen and Anita Belman and Leslie Benson and Tanuja Chitnis and Mark Gorman and Manu Goyal and Yolanda Harris and Lauren Krupp and Timothy Lotze and Soe Mar and Manikum Moodley and Jayne Ness and Moses Rodriguez and John Rose and Teri Schreiner and Jan-Mendelt Tillema and Michael Waltz and Casper, \{T. Charles\} and Emmanuelle Waubant",

note = "Objective: We assessed real-world effectiveness of initial treatment with newer compared to injectable disease-modifying therapies (DMT) on disease activity in pediatric multiple sclerosis (MS) and clinically isolated syndrome (CIS). Background: Treatment of pediatric MS is challenging as most DMTs lack randomized controlled trial data in children.",

year = "2020",

month = apr,

day = "14",

doi = "10.1212/WNL.94.15\_supplement.625",

language = "American English",

volume = "94",

journal = "Neurology",

number = "15 supplement",

}

TY - JOUR

T1 - Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)

AU - Krysko, Kristen

AU - Graves, Jennifer

AU - Rensel, Mary

AU - Weinstock-Guttman, Bianca

AU - Rutatangwa, Alice

AU - Aaen, Gregory

AU - Belman, Anita

AU - Benson, Leslie

AU - Chitnis, Tanuja

AU - Gorman, Mark

AU - Goyal, Manu

AU - Harris, Yolanda

AU - Krupp, Lauren

AU - Lotze, Timothy

AU - Mar, Soe

AU - Moodley, Manikum

AU - Ness, Jayne

AU - Rodriguez, Moses

AU - Rose, John

AU - Schreiner, Teri

AU - Tillema, Jan-Mendelt

AU - Waltz, Michael

AU - Casper, T. Charles

AU - Waubant, Emmanuelle

N1 - Objective: We assessed real-world effectiveness of initial treatment with newer compared to injectable disease-modifying therapies (DMT) on disease activity in pediatric multiple sclerosis (MS) and clinically isolated syndrome (CIS). Background: Treatment of pediatric MS is challenging as most DMTs lack randomized controlled trial data in children.

PY - 2020/4/14

Y1 - 2020/4/14

UR - https://n.neurology.org/content/94/15_Supplement/625

U2 - 10.1212/WNL.94.15_supplement.625

DO - 10.1212/WNL.94.15_supplement.625

M3 - Meeting abstract

VL - 94

JO - Neurology

JF - Neurology

IS - 15 supplement

ER -

Real-world Effectiveness of Initial Treatment with Newer versus Injectable Disease-modifying Therapies in Pediatric Multiple Sclerosis (625)

Disciplines

Access to Document

OpenUrl availability

Other files and links

Cite this